Skip to main content
AARTIPHARM · NSE
Market closedNSE | BSE
Loading live market indices
AA
NSE · Equity shares · Biotechnology & Drugs

Aarti Pharmalabs AARTIPHARM

NSE:INR 693Recorded price
BSE:INR 691.45Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 678.6 — INR 698.1
52-week rangeINR 583.85 — INR 946.45
VolumeNot available
Market cap6,302.24
P/E28.53
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,819.44
Net Income (INR Cr)174.71
P/E Ratio28.53
Book Value220.69
EPS19.48
Price/BV3.14Computed
AI and Advanced

AI analysis and Advanced tools for AARTIPHARM

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

AARTIPHARM futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

AARTIPHARM Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity3,481.712,902.432,582.11
Cash Equivalents8.536.73Not available
Other Liabilities Total7.858.126.06
Long Term Debt225.17111.26Not available
Common Stock Total45.3345.3245.31
Other Equity Total2,079.281,944.598.06
Other Current Assets Total153.6196.820
Total Assets3,481.712,902.432,582.11
Current Portof LT Debt/Capital Leases16.555.094.49
Cash1.091.9124.07
Total Equity2,124.61,989.911,757.04
Long Term Investments229.2843.2736.78
Total Common Shares Outstanding9.079.069.06
Tangible Book Valueper Share Common Eq220.69208.49185.38
Total Liabilities1,357.1912.52825.07
Total Debt793.72420.82285.25
Short Term Investments048.7276.68
Cashand Short Term Investments9.6257.37100.74
Total Receivables Net593.76576.42589.31
Notes Payable/Short Term Debt499.82292.8264.06
Deferred Income Tax134.33128.4107.92
Accounts Receivable-Trade Net583.32575.4519.34
Property/Plant/Equipment Total-Net1,706.661,410.71,093.19
Total Current Liabilities937.57653.07694.39
Total Inventory640.31587.58649.44
Accounts Payable334.54277.83378.32
Other Currentliabilities Total86.6677.3532.26
Total Long Term Debt277.35122.9316.7
Intangibles Net123.8998.4475.27
Other Long Term Assets Total16.8122.7511.33
Note Receivable-Long Term7.787.318.11
Total Current Assets1,397.291,318.191,345.64
Capital Lease Obligations52.1811.6716.7
Property/Plant/Equipment Total-GrossNot available322.011,630.04
Goodwill NetNot available1.781.78
Accumulated Depreciation TotalNot availableNot available-536.85
Accrued ExpensesNot availableNot available15.26
Prepaid ExpensesNot availableNot available6.15
Additional Paid-In CapitalNot availableNot available440.33
Retained Earnings(Accumulated Deficit)Not availableNot available1,263.34
Fundamentals

Valuation and ratios

Growth

Debt 5Yr CAGR %755.71

Margins

Operating Margin 12m16.23

Operating Margin 5y Avg17.76

Net Profit Margin 12m10.25

Net Profit Margin 5y10.97

Yield

Dividend Yield %0.51

Valuation

Price to Sale Ratio3.46

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskBalanced risk

Board Risk40.62

Analyst consensus

Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

CompanyPriceMarket capP/EResearch
Sun Pharmaceutical IndustriesINR 1,9444.66 L38.4—
Divi's LaboratoriesINR 8,291.552.20 L73.32—
Torrent PharmaceuticalsINR 4,9651.89 L72.73—
CiplaINR 1,4751.19 L27.57—
Zydus LifesciencesINR 1,106.251.10 L21.19—
Shareholding

Ownership

Promoter
42.86%
FII
8.17%
MF
0.79%
Other
48.18%
Corporate actions

Events

  1. board MeetingsQuarterly Results
  2. dividendRs.2.0000 per share(40%)Final Dividend
  3. board Meetings(Revised)
  4. board MeetingsAudited Results & Final Dividend
  5. dividendRs.1.5000 per share(30%)Interim Dividend
  6. board MeetingsQuarterly Results & Interim Dividend
  7. board MeetingsQuarterly Results
  8. annual General MeetingAGM
  9. dividendRs.2.5000 per share(50%)Final Dividend
  10. board MeetingsQuarterly Results
  11. board MeetingsAudited Results & Final Dividend
  12. dividendRs.2.5000 per share(50%)Interim Dividend
  13. board MeetingsTo consider other business matters.
  14. board MeetingsQuarterly Results
  15. annual General MeetingAGM
  16. board MeetingsQuarterly Results
  17. dividendRs.1.0000 per share(20%)Final Dividend
  18. board MeetingsAudited Results & Final Dividend
  19. dividendRs.2.0000 per share(40%)Interim Dividend
  20. board MeetingsQuarterly Results & Interim Dividend
Rusaka Markets Community

Discussion and sentiment for Aarti Pharmalabs

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. The Company's products are exported to key regulated markets such as the United States (US), the European Union, and Japan.

Company facts

Industry
Biotechnology & Drugs
Sector
Biotechnology & Drugs
NSE Code
AARTIPHARM
BSE Code
543748
Questions

Stock FAQ

What is the symbol and ISIN of Aarti Pharmalabs?

Aarti Pharmalabs has the symbol AARTIPHARM and ISIN - INE0LRU01027.

What is the latest recorded price of Aarti Pharmalabs?

The latest available recorded price of Aarti Pharmalabs is INR 693.00 as of 2026-08-06T21:04:53.258Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of Aarti Pharmalabs?

Year high: INR 946.45. Year low: INR 583.85.

What is the market capitalization of Aarti Pharmalabs?

Market capitalization: INR 6,302.24 crore.

What is the P/E ratio of Aarti Pharmalabs?

P/E ratio: 28.53.

What is the dividend yield of Aarti Pharmalabs?

Dividend yield: 0.51%.

How is the financial performance of Aarti Pharmalabs based on revenue, net income, and EPS?

Revenue: INR 1,819.44 crore. Net income: INR 174.71 crore. EPS: INR 20.81.

What is the book value of Aarti Pharmalabs?

Book value: INR 220.69.

What are the price-to-book and price-to-sales ratios of Aarti Pharmalabs?

Price-to-book ratio: 3.14. Price-to-sales ratio: 3.46.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.